Lucid Diagnostics Inc. (LUCD) earnings
LUCD earnings moved a median of 0.00% by the close. Quarterly and annual LUCD reports and results, each read against the price at its own news timestamp. Back to the LUCD overview →
22 measured LUCD earnings events.
Where these LUCD earnings landedvs 22 measured LUCD earnings reactions
| Middle 50% of LUCD earnings reactions | -2.44% to +3.70% |
|---|---|
| Median reaction (to close) | 0.00% |
| Measured reactions | 22 |
Point-in-time · zero look-ahead
Half of the 22 LUCD earnings events with a measured close landed between -2.44% and +3.70%; 45% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results | Press release | -0.87% | -1.54% | |
| Form 10-Q Lucid Diagnostics Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.87% | -1.54% | |
| Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 | Press release | +2.15% | -1.00% | |
| Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results | Press release | +1.49% | +0.99% | |
| Form 10-Q Lucid Diagnostics Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.49% | +0.99% | |
| Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 | Press release | +0.48% | +2.88% | |
| Form 10-K Lucid Diagnostics Inc. For: Dec 31 | SEC filing · Form 10-K | +2.10% | -3.36% | |
| Form 10-Q Lucid Diagnostics Inc. For: Sep 30 | SEC filing · Form 10-Q | +1.92% | +6.73% | |
| Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | +1.92% | +6.73% | |
| Lucid Diagnostics Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | -3.92% | -3.81% | |
| Form 10-Q Lucid Diagnostics Inc. For: Jun 30 | SEC filing · Form 10-Q | -3.92% | -3.81% | |
| Lucid Diagnostics Provides Business Update and Reports First Quarter 2025 Financial Results | Press release | +5.31% | +13.27% | |
| Form 10-Q Lucid Diagnostics Inc. For: Mar 31 | SEC filing · Form 10-Q | +5.31% | +13.27% | |
| Form 10-K Lucid Diagnostics Inc. For: Dec 31 | SEC filing · Form 10-K | -7.14% | -2.60% | |
| Lucid Diagnostics Provides Business Update and Third Quarter 2024 Financial Results | Press release | +0.06% | -4.54% | |
| Form 10-Q Lucid Diagnostics Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.06% | -4.54% | |
| Form 10-Q Lucid Diagnostics Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.05% | +3.70% | |
| Lucid Diagnostics Provides Business Update and Second Quarter 2024 Financial Results | Press release | -1.05% | +3.70% | |
| Form 10-Q Lucid Diagnostics Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.07% | +0.00% | |
| Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results | Press release | -1.07% | +0.00% | |
| Form 10-K Lucid Diagnostics Inc. For: Dec 31 | SEC filing · Form 10-K | +0.72% | -1.98% | |
| Form 10-Q Lucid Diagnostics Inc. For: Sep 30 | SEC filing · Form 10-Q | +4.17% | +20.37% |
Keep exploring
More LUCD: analyst actions → · SEC filings → · LUCD overview →